Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS).

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

April 17, 2019

Study Completion Date

May 31, 2019

Conditions
Ankylosing Spondylitis
Interventions
OTHER

Physiotherapy

"Participants, with a confirmed diagnosis of AS, will be invited to participate. Once participants have provided informed consent, they will be required to complete the outcome measures provided. Participants will be set up to use the online exercise application and educated on its use.~Participants will then have access to videos of suitable exercises or exercise classes to follow and education material on their condition to read. Participants will be able to complete AS specific outcome measures and record their progress. Participants will also have a monthly video call with the senior rheumatology physiotherapist to discuss their exercise programme, symptoms and management. The participants will also record their compliance with their exercise programmes.~After the 6 month pilot period, participants will be required to complete the same outcome measures completed at the start of the study."

Trial Locations (1)

Unknown

RECRUITING

Physiotherapy Department, Saint James's Hospital, Dublin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Salaso Health Solutions Limited

UNKNOWN

collaborator

Novartis

INDUSTRY

lead

St. James's Hospital, Ireland

OTHER

NCT03457285 - Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS). | Biotech Hunter | Biotech Hunter